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The unfolded protein response (UPR) coordinates translational and transcriptional changes triggered by
unfolded proteins within the endoplasmic reticulum. Two recent papers (Oliveira et al., 2009; Vecchi et al.,
2009) show that the UPRmodulates transcription of the hormone hepcidin, which controls plasma iron levels
and perhaps innate immunity.Hepcidin is a major regulator of mamma-
lian iron homeostasis and modulates
cellular iron efflux by binding to ferropor-
tin, the only known iron exporter, and
inducing its internalization and degrada-
tion (Nemeth et al., 2004b). The produc-
tion of hepcidin is greatly stimulated by
inflammation. By decreasing plasma iron
and limiting pathogen access to iron, hep-
cidin is thought to play an important role in
innate immunity. Inflammation can lead to
hepcidin production through the direct
activation of Toll-like receptors (Peysson-
naux et al., 2006) or through inflammatory
cytokines such as interleukin-6 (IL-6)
(Nemeth et al., 2004a). Two recent papers
have uncovered a new route to hepcidin
induction through activation of the
unfolded protein response (UPR) in the
endoplasmic reticulum (ER) (Oliveira
et al., 2009; Vecchi et al., 2009).
The ER, well recognized as a sophisti-
cated machine for protein folding and
secretion, has functions beyond protein
trafficking. The ER can act as a signal-
transduction system affecting cellular
physiology. Conditions that lead to accu-
mulation of unfolded proteins in the ER
(such as viral infection or alteration of
redox status) promote the evolutionarily
conserved signaling pathway termed the
UPR (for review, see Bernales et al.,
2006). The initial role of the UPR is to
reestablish normal ER function. Induction
of the UPR leads to decreased rates of
protein translation, which prevents further
accumulation of unfolded proteins. The
UPRalso results in increased transcription
of ER-resident chaperones and pro-
teinase degradation systems, which can
reduce accumulated protein aggregates.This coordinated response allows for the
elimination of unfolded proteins and rees-
tablishes cellular homeostasis. Recent
studies have indicated that the UPR
system has effects that extend beyond
the cellular level and can affect the or-
ganism systemically. Most notably, the
UPR system was shown to induce the
acute-phase response and may be an
integral part of innate immunity (Zhang
et al., 2006). The involvement of the UPR
in innate immunity has been recently
strengthened by two papers, which dis-
covered that ER stress regulates hepcidin
production
The UPR, triggered by formation of
unfoldedproteinaggregates,usesanevolu-
tionarily conserved signaling pathway in
which the presence of unfolded proteins
within the ER activates a set of ER-located
sensors. By various routes, activation of
these sensors leads to increased expres-
sion of transcription factors. One such
factor is cAMP-responsive element-bind-
ing protein H (CREBH). CREBH expres-
sion is restricted to the liver, and CREBH
levels increase in response to proinflam-
matory cytokines and inducers of ER
stress (Zhang et al., 2006). Many of the
genes regulated by CREBH encode
acute-phase reactants: plasma proteins
that increase in response to inflammation.
Vecchi et al. now show that induction of
the acute-phase response in cultured
hepatoma cells by agents such as tunica-
mycin leads to increased hepcidin tran-
scription (Vecchi et al., 2009). Manymem-
brane and secreted proteins are insoluble
in the absence of N-linked glycosylation.
Tunicamycin, an inhibitor of N-linked gly-
cosylation in the ER, leads to decreasedCell Metabolism 1protein solubility and increases the UPR.
Vecchi et al. go on to show that specific
sequences in the hepcidin promoter re-
gion respond to CREBH and that ectopic
expression of CREBH in nonhepatocyte
cells induces hepcidin mRNA. To explore
the physiological role of CREBH in hepci-
din production, Vecchi et al. used mice
homozygous for a targeted deletion in
CREBH. Treatment of wild-type mice
with tunicamycin resulted in robust
expression of hepcidin, whereas tunica-
mycin-treated CREBH knockdown mice
showed reduced induction of hepcidin
expression. Treatment of CREBH knock-
out mice with the ‘‘classic’’ inflammatory
mediator LPS still induced hepcidin ex-
pression, although again, expression
was reduced compared towild-typemice.
These results indicate that the CREBH-
hepcidin pathway is involved in regulating
hepcidin during inflammation but is not
solely responsible.
Oliveira et al. also show that ER stress
can result in hepcidin expression by a
mechanism that may be independent of
CREBH. These authors showed that acti-
vation of the UPR in cultured hepatoma
cells by the ER stressors homocysteine
and dithiothreitol led to induction of hepci-
din transcription. Hepcidin transcription
in cultured cells was complex, varying
with the dose of the ER stressor and with
time. In their studies, hepcidin transcription
showed greater increases with continued
ER stress. They correlated the increase in
hepcidin transcription with a decrease in
the expression of the transcription factor
CCAAT/enhancer-binding protein (C/EBP)
homologous protein (CHOP). CHOP func-
tions as a heterodimer, and by binding to0, October 7, 2009 ª2009 Elsevier Inc. 245
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PreviewsFigure 1. Model for the Regulation of Hepcidin Expression by ER Stress and Inflammation
Activation of the UPR increases expression of CHOP and CREBH, two liver-specific transcription factors.
CREBH, induced by inflammatory stimuli (LPS, IL-6), enhances hepcidin synthesis by binding to elements
in the hepcidin (HAMP) promoter. Depending upon the level of ER stress, the initial induction of CHOPmay
bind to C/EBPa at the HAMP promoter and repress hepcidin synthesis. Decreased expression of CHOP
would then increase hepcidin transcription. It is unclear how LPS and IL-6 lead to ER stress. LPS and IL-6
also activate hepcidin transcription through the Stat3 pathway.the C/EBP family of transcription factors,
CHOP can inhibit transcription. The
C/EBP isoform C/EBPa has been shown
to activate hepcidin (Courselaud et al.,
2002). The decrease in CHOP as a result
of the UPR would result in an increase in
hepcidin transcription due to increased
C/EBPa. Oliveira et al. showed that deple-
tion of C/EBPa by siRNA reduced but did
not prevent the induction of hepcidin
expression by the UPR. This result indi-
cates that C/EBPa and thus changes
in CHOP are not solely responsible for
hepcidin transcription. It is tempting to
speculate that the early response of
hepcidin transcription to UPR as well as
hepcidin transcription in the absence of
C/EBPa was due to CREBH. Similarly,
the UPR induction of hepcidin in the
absence of CREBH might be due to
C/EBPa (Figure 1).
These two studies demonstrate a link
between ER stress and hepcidin produc-
tion. In both studies, reducing expression
of the respective transcription factors by
RNA silencing did not inhibit hepcidin
synthesis in vitro or in vivo. These data246 Cell Metabolism 10, October 7, 2009 ª2suggest that CREBH and C/EBPa may
act in concert with other transcription
factors. In hepatocytes, LPS and IL-6
lead to hepcidin transcription through
the Stat family of transcription factors
(Verga Falzacappa et al., 2007). Both
CREBH and CHOP are hepatocyte spe-
cific, but hepcidin can be expressed by
cells other than hepatocytes in response
to inflammation. In macrophages, inflam-
matory agents such as bacterial products
can activate hepcidin transcription
through Toll-like receptors (Peyssonnaux
et al., 2006; Koening et al., 2009). Does
the UPR in macrophages lead to hepcidin
transcription? If so, what transcription
factors are involved? The multiplicity of
mechanisms that lead to inflammation-
induced changes in hepcidin transcription
suggests the importance of hepcidin in
innate immunity.
The new work by Oliveira et al. and
Vecchi et al. demonstrate a direct link
between inflammation and the intracel-
lular stress response in modulating local
or systemic iron traffic through hepcidin
production. These studies also suggest009 Elsevier Inc.that hepcidin may be regulated differently
in acute versus chronic stress. An acute
drop in plasma iron in response to inflam-
mation is thought to be beneficial, as it
may limit a pathogen’s access to iron. In
contrast, chronic inflammation may lead
to iron-limited erythropoiesis and anemia
due to a persistent reduction in plasma
iron. The anemia of chronic inflammation
complicates other medical conditions.
For example, anemia in the elderly
increasesmortality due to all other causes
(Zakai et al., 2005). The discovery that
UPR leads to increased hepcidin expres-
sion may provide further insight into
mechanisms that contribute to chronic
anemia.
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